Aura Biosciences AURA Stock
Aura Biosciences Price Chart
Aura Biosciences AURA Financial and Trading Overview
| Aura Biosciences stock price | 7.99 USD |
| Previous Close | 7.72 USD |
| Open | 7.81 USD |
| Bid | 5.18 USD x 200 |
| Ask | 9.22 USD x 200 |
| Day's Range | 7.72 - 8 USD |
| 52 Week Range | 4.73 - 9.54 USD |
| Volume | 526.75K USD |
| Avg. Volume | 556.79K USD |
| Market Cap | 826.46M USD |
| Beta (5Y Monthly) | 0.396 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.8 USD |
AURA Valuation Measures
| Enterprise Value | 700.4M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.9359605 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.778708 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.96 |
Trading Information
Aura Biosciences Stock Price History
| Beta (5Y Monthly) | 0.396 |
| 52-Week Change | 3.52% |
| S&P500 52-Week Change | 18.95% |
| 52 Week High | 9.54 USD |
| 52 Week Low | 4.73 USD |
| 50-Day Moving Average | 6.96 USD |
| 200-Day Moving Average | 6.38 USD |
AURA Share Statistics
| Avg. Volume (3 month) | 556.79K USD |
| Avg. Daily Volume (10-Days) | 345.81K USD |
| Shares Outstanding | 103.44M |
| Float | 93.3M |
| Short Ratio | 7.8 |
| % Held by Insiders | 1.15% |
| % Held by Institutions | 49.31% |
| Shares Short | 5.61M |
| Short % of Float | 5.45% |
| Short % of Shares Outstanding | 5.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -50.59% |
| Return on Equity (ttm) | -95.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -117510000 USD |
| Net Income Avi to Common (ttm) | -112393000 USD |
| Diluted EPS (ttm) | -1.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 114.73M USD |
| Total Cash Per Share (mrq) | 1.11 USD |
| Total Debt (mrq) | 16.99M USD |
| Total Debt/Equity (mrq) | 15.84 USD |
| Current Ratio (mrq) | 7.093 |
| Book Value Per Share (mrq) | 1.672 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -91280000 USD |
| Levered Free Cash Flow (ttm) | -51558752 USD |
Profile of Aura Biosciences
| Country | United States |
| State | MA |
| City | Boston |
| Address | 80 Guest Street |
| ZIP | 02135 |
| Phone | 617 500 8864 |
| Website | https://www.aurabiosciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 113 |
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Q&A For Aura Biosciences Stock
What is a current AURA stock price?
Aura Biosciences AURA stock price today per share is 7.99 USD.
How to purchase Aura Biosciences stock?
You can buy AURA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aura Biosciences?
The stock symbol or ticker of Aura Biosciences is AURA.
Which industry does the Aura Biosciences company belong to?
The Aura Biosciences industry is Biotechnology.
How many shares does Aura Biosciences have in circulation?
The max supply of Aura Biosciences shares is 94.83M.
What is Aura Biosciences Price to Earnings Ratio (PE Ratio)?
Aura Biosciences PE Ratio is now.
What was Aura Biosciences earnings per share over the trailing 12 months (TTM)?
Aura Biosciences EPS is -1.71 USD over the trailing 12 months.
Which sector does the Aura Biosciences company belong to?
The Aura Biosciences sector is Healthcare.
Aura Biosciences AURA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26342.9 USD — |
-0.08
|
5.14B USD — | 26208.43 USD — | 26499.42 USD — | — - | 5.14B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2307.21 USD — |
+0.6
|
— — | 2287.61 USD — | 2323.3 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1262.13 USD — |
-0.47
|
— — | 1260.6 USD — | 1279.07 USD — | — - | — — |
- {{ link.label }} {{link}}
